Research Progress on Traditional Chinese Medicine Regulating Ferroptosis for the Prevention and Treatment of Diabetic Retinopathy
DOI:
Author:
Corresponding Author:

Affiliation:

1.Shaanxi University of Chinese Medicine;2.Affiliated Hospital of Shaanxi University of Chinese Medicine

Clc Number:

Fund Project:

Shaanxi Provincial Natural Science Foundation (No. 2021JQ‑739); Xianyang Science and Technology Program Project (No. L2025‑ZDYF‑JBFZ‑021)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Abstract Diabetic retinopathy (DR), a highly prevalent microvascular complication of diabetes mellitus (DM) with severe harmfulness and prominent risk of blindness, suffers from limitations including insufficient efficacy and single-target defects in existing clinical interventions. Ferroptosis is a type of iron ion-dependent programmed cell death mediated by lipid peroxidation. It mediates retinal cell injury mainly through three core pathways: the Xc?/GSH/GPX4 antioxidant axis, the iron metabolism homeostasis regulatory axis, and the lipid peroxidation metabolism axis, and participates in the occurrence and development of DR. Traditional Chinese medicine (TCM) intervention for DR has unique advantages of multi-target synergistic effect and relatively low toxicity and side effects. Existing studies have confirmed that a variety of traditional Chinese medicine monomers can alleviate ferroptosis-induced injury of retinal cells through multiple mechanisms, including activating the Nrf2/GPX4 antioxidant pathway, remodeling cellular iron metabolism homeostasis, and down-regulating the expression of ACSL4, a key enzyme promoting ferroptosis; while traditional Chinese medicine compound prescriptions exert retinal protective effects mainly by up-regulating the Nrf2/GPX4 antioxidant axis and activating PINK1/Parkin pathway-mediated mitophagy. However, current studies in this field are mainly based on in vitro cell and animal experimental evidence, and there are still several academic controversies with relatively insufficient clinical translational evidence. This paper sorts out the core regulatory mechanism of ferroptosis and the evidence for its involvement in DR pathological injury, summarizes existing studies on TCM targeting ferroptosis regulation for DR intervention, and provides theoretical references for the subsequent development of TCM prevention and treatment strategies for DR.

    Reference
    Related
    Cited by
Get Citation
Article Metrics
  • Abstract:
  • PDF:
Publication History
  • Received:July 10,2026
  • Revised:November 10,2026
  • Adopted:September 11,2026
  • Online: November 11,2026
  • Published: